Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) ...
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today ...
Cambridge, Massachusetts Tuesday, March 10, 2026, 18:00 Hrs [IST] ...
Rosalind Franklin University of Medicine and Science has doubled the space for one of Chicagoland's top startup support programs.
Positions Lifeward as a diversified biomedical innovation company with clear path to profitabilityIntegration of Oramed’s POD™ oral delivery ...
THE FIRST PRODUCT IS SHIPPING. With the full rebrand of Researgency.ai now complete, the platform is live and ready for enterprise clients. Kala’s scientists, working alongside Younet’s AI engineering ...
The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong ...
A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the ...
From Zimbabwe to Zambia, US health deals are raising fears of a new era of biomedical extractivism.
Funding from the National Institutes of Health (NIH) generated $94.15 billion in economic activity and supported 390,863 jobs in 2025, according to a ...
Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results